Licensed vs unlicensed- to make medicines, or to buy them?

摘要

Many hospital manufacturing units have reported escalating activity during recent years - particularly in the supply of cytotoxic chemotherapy This has increased pressure on staff and facilities, which in turn introduces risk. Last year's National Patient Safety Agency (NPSA) alerts (20 and 21) on injectable medicines added to this pressure.To address the situation, many hospital pharmacy manufacturing units recruit more staff or expand their facilities.